[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-337708-105":59,"doc-detail-337708-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","estrogen-receptor-mediated-signaling-inhibits-type-i-interferon-response-to-promote-breast-carcinogenesis","Estrogen receptor α-mediated signaling inhibits type I interferon response to promote breast carcinogenesis","","Estrogen receptor α (ERα) is a key driver and therapeutic target in about 70% of breast cancers. This study identifies ERα as a negative regulator of type I interferon signaling. ERα activation by estradiol suppresses IFN-β–induced transcription of interferon-stimulated genes, while ERα deficiency or fulvestrant shows opposite effects. Mechanisms include H2A.Z induction restricting ISGF3 promoter engagement and ERα–STAT2 interaction disrupting ISGF3 assembly, jointly inhibiting ISG transcription. In vivo, fulvestrant enhances IFN-β control of ERα+ tumors, and clinical analysis links higher ISG levels to better long-term survival.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/estrogen-receptor-mediated-signaling-inhibits-type-i-interferon-response-to-promote-breast-carcinogenesis/337708/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/estrogen-receptor-mediated-signaling-inhibits-type-i-interferon-response-to-promote-breast-carcinogenesis/337708.png","ImageObject",300,407,{"name":92,"@type":93},"Aurora","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-03","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"How does ERα influence type I interferon signaling in breast cancer?","Question",{"text":112,"@type":113},"ERα acts as a negative regulator of the type I interferon response. ERα activation inhibits IFN-β–induced transcription of interferon-stimulated genes, while loss or antagonism of ERα produces opposite effects.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What two mechanistic events explain how ERα inhibits ISG transcription?",{"text":117,"@type":113},"ERα induces H2A.Z to restrict ISGF3 engagement at ISG promoters and interacts with STAT2 to disrupt ISGF3 complex assembly. These events jointly suppress ISG transcription triggered by type I IFNs.",{"name":119,"@type":110,"acceptedAnswer":120},"What evidence supports the functional impact of fulvestrant on interferon effects?",{"text":121,"@type":113},"In a xenograft mouse model, fulvestrant strengthens IFN-β’s ability to suppress ERα+ breast tumor growth. Clinical data analysis further shows that ERα+ patients with higher ISG levels have higher long-term survival rates.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},337708,1790211788,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},4810365810221,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Journal of Molecular Cell Biology (2023), 15(7), mjad047 [https://doi.org/10.1093/jmcb/mjad047](https://doi.org/10.1093/jmcb/mjad047)  \nPublished online July 13, 2023  \nArticle  \nEstrogen receptor α-mediated signaling inhibits type I interferon response to promote breast carcinogenesis  \nLi-Bo Cao1 , 2 ,3 , Zi-Lun Ruan Cheguo Cai1 , 2 ,3 , Jing Zhang  \n1 , 2 ,3 , Yu-Lin Yang1 , 2 ,3 , Nian-Chao Zhang1 , 2 ,3 , Chuan Gao1 , 2 ,3 , 1 , 2 ,3 , Ming-Ming Hu1 , 2 ,3 , * , and Hong-Bing Shu1 , 2 ,3 , *  \n1 Department of Infectious Diseases, Medical Research Institute, Zhongnan Hospital of Wuhan University, College of Life Sciences, Wuhan University, Wuhan 430072, China  \n2 Frontier Science Center for Immunology and Metabolism, Taikang Center for Life and Medical Sciences, Wuhan University, Wuhan 430072, China  \n3 Research Unit of Innate Immune and Inﬂammatory Diseases, Chinese Academy of Medical Sciences, Wuhan 430072, China  \n* Correspondence to: Ming-Ming Hu, [E-mail:](E-mail: mmhu@whu.edu.cn)[ mmhu@whu.edu.cn](E-mail: mmhu@whu.edu.cn); Hong-Bing Shu, E-mail: [shuh@whu.edu.cn](shuh@whu.edu.cn)  \nEdited by Zhiyuan Shen  \nEstrogen receptor α (ERα) is an important driver and therapeutic target in ∼70% of breast cancers. How ERα drives breast carcinogenesis is not fully understood. In this study, we show that ERα is a negative regulator of type I interferon (IFN) response. Activation of ERα by its natural ligand estradiol inhibits IFN-β-induced transcription of downstream IFN-stimulated genes (ISGs), whereas ERα deﬁciency or the stimulation with its antagonist fulvestrant has opposite eﬀects. Mechanistically, ERα induces the expression of the histone 2A variant H2A.Z to restrict the engagement of the IFN-stimulated gene factor 3 (ISGF3) complex to the promoters of ISGs and also interacts with STAT2 to disrupt the assembly of the ISGF3 complex. These two events mutually lead to the inhibition of ISG transcription induced by type I IFNs. In a xenograft mouse model, fulvestrant enhances the ability of IFN-β to suppress ERα+ breast tumor growth. Consistently, clinical data analysis reveals that ERα+ breast cancer patients with higher levels of ISGs exhibit higher long-term survival rates. Taken together, our ﬁndings suggest that ERα inhibits type I IFN response via two distinct mechanisms to promote breast carcinogenesis.  \nKeywords: estrogen receptor, type I interferon, breast cancer  \nIntroduction  \nBreast cancer has become one of the most common and fatal cancer types in the world (Loibl et al., 2021) . Estrogen receptor α(ERα), a nuclear hormone receptor (HR), is expressed in ∼70% of breast cancers and is an important therapeutic target for ERα+ breast cancer (Harvey et al., 1999 ; Sledge et al., 2014) . Previous studies suggested that ERα promotes breast carcinogenesis by up-regulating proliferation regulators, including survivin, growth factors, and cell cycle-related genes. For example, estradiol (E2), a natural ligand of ERα, activates cyclin-dependent kinase 4 by up-regulating cyclin D expression, thereby promoting cell cycle  \nReceived October 20, 2022 . Revised February 22, 2023 . Accepted July 12, 2023 .© The Author(s) (2023) . Published by Oxford University Press on behalf of Journal of Molecular Cell Biology, CEMCS, CAS.  \nThis is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License ([https://creativecommons.org/licenses/by](https://creativecommons.org/licenses/by)nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use,  \nplease contact [journals.permissions@oup.com](journals.permissions@oup.com)  \nprogression (Frasor et al., 2003) . A recent study demonstrated that ERα acts as an RNA-binding protein to sustain tumor cell survival and drug resistance by regulating RNA metabolism (Xu et al., 2021) . In addition, several chemical inhibitors that target ERα have been us","cbCaia3efBksahuG","https://ap.wps.com/l/cbCaia3efBksahuG","pdf",2166327,14,"English","# Abstract\n# Introduction\n## Breast cancer and ERα as a therapeutic target\n## Type I interferons and ISGF3-driven ISG transcription","[{\"question\":\"How does ERα influence type I interferon signaling in breast cancer?\",\"answer\":\"ERα acts as a negative regulator of the type I interferon response. ERα activation inhibits IFN-β–induced transcription of interferon-stimulated genes, while loss or antagonism of ERα produces opposite effects.\"},{\"question\":\"What two mechanistic events explain how ERα inhibits ISG transcription?\",\"answer\":\"ERα induces H2A.Z to restrict ISGF3 engagement at ISG promoters and interacts with STAT2 to disrupt ISGF3 complex assembly. These events jointly suppress ISG transcription triggered by type I IFNs.\"},{\"question\":\"What evidence supports the functional impact of fulvestrant on interferon effects?\",\"answer\":\"In a xenograft mouse model, fulvestrant strengthens IFN-β’s ability to suppress ERα+ breast tumor growth. Clinical data analysis further shows that ERα+ patients with higher ISG levels have higher long-term survival rates.\"}]","Estrogen receptor α-mediated signaling inhibits type I interferon response to promote breast carcinogenesis | PDF",1790020283,35,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/044b2b0aca6dec6da3b796b7d5a826a0.webp",983,1269,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1bb6b94a9025ded15544912423a48b58.webp",982,1268,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4f2d2fd629a4d8fd64ae79c2042bc269.webp",981,1266,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/49602407d9c4d2ff428ccccd97fcf086.webp",980,1265]